Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Vinyl Acetate | HCID 7904 | — |
| Reactant | HCID 11348115 | HCID 11348115 | — |
| Solvent | Diisopropyl Ether | HCID 7914 | — |
| Product | HCID 11359478 | HCID 11359478 | — |
Reaction Steps
5-Hydroxymethyl-1-(p-toluenesulfonyl)-2,3,4,5-tetrahydro-1H-benzazepine (9.94 g) is dissolved in diisopropyl ether (150 ml), and thereto are added with stirring vinyl acetate (7.75 g) and Lipase QL (8%) (0.80 g) at -2° C. The mixture is stirred at -2° C. to 1° C. for 1.5 hour. The Lipase QL is removed by filtration on celite, and the filtrate is evaporated under reduced pressure, and the resulting residue is purified by silica gel column chromatography (solvent; n-hexane:ethyl acetate=3:1→1:1) to give (5S)-5-hydroxymethyl-1-(p-toluenesulfonyl)-2,3,4,5-tetrahydro-1H-benzazepine (hereinafter, referred to as Compound C) (4.54 g) and (5R)-5-acetyloxymethyl-1-(p-toluenesulfonyl)-2,3,4,5-tetrahydro-1H-benzazepine (hereinafter, referred to as Compound D) (5.63 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06096736 |
|---|
| Source dataset | uspto-grants-2000_08 |
|---|
| ORD ID | ord-cb4580d3528a494384d8ce2b7086a9d8 |
|---|
| Source note | uspto-grants-2000_08 |
|---|